Back

Fractyl shares plunge 68.03% after Revita data disappoints, lawsuit alleges

Verifying
  • Pomerantz LLP announced a securities class action against Fractyl Health and certain officers.
  • 68.03%: Fractyl shares fell to $0.585 on January 29, 2026.
  • Investors have until October 20, 2026, to seek lead plaintiff appointment.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.